As a leader in quality, innovation, and capacity, we are equipped to efficiently meet your demand, no matter the scale. With expertise in media manufacturing, scalable solutions and format conversion, our proven team and leading services can help enhance your workflows. From non-GMP media prototyping to manufacturing your own formulation for production and custom packaging we can support your entire media manufacturing journey.
From small scale non-GMP manufacturing in our Gibco Rapid Prototyping Services labs to cGMP batches in our animal origin and animal origin–free facilities, we offer tailored media manufacturing services to suit your needs, no matter the developmental stage. We also offer Media Customization Services for our catalog products. Discover how we can accelerate your manufacturing journey.
| Media Customization Services | Gibco Rapid Prototyping Services | cGMP Media Manufacturing Services |
| Customize Gibco catalog products—add or remove components, create customized packaging options, select QC tests, and more. | Accelerate media development and scale up with fast, non-GMP, custom media manufacturing at pilot scale. | Outsource the manufacturing of your own media formulation and benefit from supply assurance, consistent quality, and our global site equivalency. |
| Learn about catalog media customization options › | Learn about non-GMP small batch media manufacturing services › | Learn about cGMP media manufacturing and site equivalency › |
Empowering your speed, scale, and supply
Backed by 60 years of bioprocessing knowledge and innovation, we are dedicated to supporting the biopharmaceutical industry by providing state-of-the-art Gibco products and trusted technical support services. Read how we are continuing our commitment to providing a dependable supply of innovative cell culture solutions. Get your copy of our special 60th anniversary media manufacturing brochure.
Combined with global manufacturing redundancy, harmonized large capacity facilities, and secondary and even tertiary material sourcing, we are uniquely positioned to support your projects, keeping you on time and on track.
Learn more about Gibco site harmonization, quality and risk mitigation processes:
We’ve invested in equivalency at our global facilities to meet our stringent redundancy requirements. This helps us offer you a continuous and uninterrupted supply of our products worldwide. You can be sure you are getting the same product, delivered on time, even during challenging times.
Our equivalency strategy includes:
|
|
We are committed to your success. By maintaining a standard of unassailable quality and continuous process improvement, our quality management systems and policies are designed to meet your ever-changing needs. Our world-class facilities receive over 200 audits each year to confirm compliance and our strict control over raw materials, including ongoing audits and testing enabled by deep analytical expertise, can help reduce your risk in biologics production, allowing you to focus on bringing your drug to market.
Our quality is reflected in your quality; the consistency of our products means you can deliver a dependable and scalable solution from batch to batch.
Our manufacturing infrastructure allows for continuity of supply and global redundancy. With manufacturing sites around the world and leading cell culture manufacturing capacity, we have the ability to meet your needs, whether large or small. We are the world's leading supplier to the biopharmaceutical industry, and together with primary operations in Grand Island, NY, Paisley, Scotland, Miami, FL, and additional prototyping and analytical labs globally, we provide a high degree of assurance of uninterrupted supply.
A strong supply chain is critical to the success of managing supplier risk. We employ a rigorous raw material supplier qualification program, along with multiple suppliers for supply continuity and robust supply chains to help keep your projects on track.
We also understand the importance of supply chain transparency for better visibility of, and access to, your supply base. We employ a multi-layered business continuity and risk mitigation plan for our partners, including:
You can maintain control of your processes—through continuous visibility and open and active communication. We pride ourselves on our understanding of these needs and the processes we have in place to address them.
We’ve invested in equivalency at our global facilities to meet our stringent redundancy requirements. This helps us offer you a continuous and uninterrupted supply of our products worldwide. You can be sure you are getting the same product, delivered on time, even during challenging times.
Our equivalency strategy includes:
|
|
We are committed to your success. By maintaining a standard of unassailable quality and continuous process improvement, our quality management systems and policies are designed to meet your ever-changing needs. Our world-class facilities receive over 200 audits each year to confirm compliance and our strict control over raw materials, including ongoing audits and testing enabled by deep analytical expertise, can help reduce your risk in biologics production, allowing you to focus on bringing your drug to market.
Our quality is reflected in your quality; the consistency of our products means you can deliver a dependable and scalable solution from batch to batch.
Our manufacturing infrastructure allows for continuity of supply and global redundancy. With manufacturing sites around the world and leading cell culture manufacturing capacity, we have the ability to meet your needs, whether large or small. We are the world's leading supplier to the biopharmaceutical industry, and together with primary operations in Grand Island, NY, Paisley, Scotland, Miami, FL, and additional prototyping and analytical labs globally, we provide a high degree of assurance of uninterrupted supply.
A strong supply chain is critical to the success of managing supplier risk. We employ a rigorous raw material supplier qualification program, along with multiple suppliers for supply continuity and robust supply chains to help keep your projects on track.
We also understand the importance of supply chain transparency for better visibility of, and access to, your supply base. We employ a multi-layered business continuity and risk mitigation plan for our partners, including:
You can maintain control of your processes—through continuous visibility and open and active communication. We pride ourselves on our understanding of these needs and the processes we have in place to address them.
No matter your customization needs, our team can offer tailored support to ease your journey. Learn more about our customization options below.
| Cell culture media formats | Custom packaging | QC testing |
| We offer custom cell culture media batches from 1 to 10,000 liters of liquid and 1 to 5,000 kg of powder. This includes our easy-to-use standard dry powder media (DPM) and our cutting-edge Advanced Granulation Technology (AGT) dry media format. | We offer a variety of standard and custom packaging options including BioProcess Containers (BPCs), flexible and rigid containment solutions to meet your custom cell culture needs. | In addition to testing for standard pH, osmolality, and sterility, we offer many additional QC tests, including trace element analysis. Choose from a broad range of tests that you may add to your custom media order. |
| Learn more about our custom media formats › | Learn more about our custom packaging options › |
Partner with Gibco PD-Express Services for unique bioproduction solutions developed to meet your early phase needs and advance your goals. We offer a variety of contract services to solve cell line, media, and process development challenges.
Let us be your advantage. Learn more about our process development services ›
Brochure: Gibco PD-Express Services
Brochure: Scaling up with Gibco media
Flyer: Trace element finished-good testing for cell culture media
Flyer:Gibco Rapid Prototyping Service
Access a targeted collection of scientific application notes, case studies, posters, white papers and more for bioprocessing:
